Beta receptor blocker was used in 81% of patients, angiotensin converting enzyme inhibitor or angiotensin receptor blocker in 82% of patients, and aldosterone antagonists in 81% of patients, which indicated that most of these patients received standard therapy for heart failure. The gene discussed is ACE; the disease is heart failure.